Objective: The smoking effect was appreciated in hypertension patients, depending on the glucose metabolism deviation degree. It is reminded that the smoking is related with the increase of resistance in the insulin in patients with diabetes Type 1, increasing the Glycosylated Hemoglobin (HbA1C).Design and Method: 135 individuals (69 smokers and 66 not smokers) with arterial hypertension, without further complications and with means age 56 AE 9,7 years, were studied. They were submitted in complete clinical and laboratorial examination. The fast glucose and the HbA1C values were determined in serum. The glucose value was measured again after oral administration of 75 gr glucose and their smoking habit were recorded.Results: As you can see at the table.Conclusions: 1) he mild deviations of glucose metabolism, like as the fast glucose disturbances, as well as the glucose tolerance disturbances, the smoking does not appear to influence the HbA1C levels.2) The smoking effect of HbA1C level is enough important (p < 0,05) in hypertension patients with Type 2 diabetes. Consequently, the smoking habit of these patients should always are taken into consideration.Objective: The relation between the glycosylated hemoglobin (HbA1c) level, Arterial Pressure (AP) and the Body Mass Index (BMI) were recorded in the diabetic patients that were under treatment. Also, this relation was evaluated as regulation criterion of these patients.Design and Method: 192 cases of diabetic patients were studied. 118 out of 192 (61,5%) had BMI !25 and 74 out of 192 (38,5%) BMI<25. 113 out of 118 (95,8%) patients received antidiabetic tablet, while 53 out of 118 (44,9%) patients simultaneously received also anti-hypertension treatment. All of the 74 patients with BMI<25, without exception, received tablet for diabetes (percentage 100%), while 29 (39,1 %) of these patients received simultaneous treatment of anti-hypertension medicines. The HbA1c 7% and AP 130/80mmHg values were considered as satisfactory regulation criteria.Results: As you can see at the table.Conclusions: 1) The major percentage of diabetic patients (61,5%) has BMI !25. In regard to the HbA1c and AP values, except therapeutic objective, were found to be 63,6% and 56%, respectively. It is a very disappointed rate. 2) In the other side, patients with BMI<25 present greater rate of therapeutic target achievement, with regard to the HbA1c level. This percentage (50%) is not also judged as satisfactory. 3) With regard to the levels of AP, does not exist important difference between the first and second team since a very high percentage (44,6%) is also found except therapeutic objective. 4) It is imposed, consequently, to exist further diatetic treatment or even pharmaceutical intervention in the diabetic patients of both teams and especially in the first team. 5) The relation of HbA1c and AP concerning the BMI constitute a useful, practical and reliable indicator -criterion of these patients' regulation.
